For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
Coronavirus News is a section dedicated to the new coronavirus that is causing an epidemic in China and fast spreading globally. The strain of coronavirus called Covid-19 or also commonly called the Wuhan coronavirus is genetically more potent and faster spreading than the SARS coronavirus. Currently teams are working to develop a new vaccine for this new coronavirus while other teams are trying t...
Source: COVID-19 Nutrition Jul 21, 2020 4 years ago
COVID-19 Nutrition: A study by researchers in Europe claims that COVID-19 mortality rates may be lower in countries where individuals consume high amounts of cabbage and cucumber.
Increasing average daily consumption of the vegetables by 1 gram may cut mortality rate, according to research, which has not been peer-reviewed. The research findings are published on a preprint server. https:/...
Source: COVID-19 Ventilators Jul 21, 2020 4 years ago
COVID-19 Ventilators: A recent study by researchers from University Of Liverpool and Liverpool University Hospitals show that the administration of continuous positive airway pressure (CPAP) may help in avoiding mechanical ventilation in COVID-19 patients.
The results of the study are significant as CPAP is less invasive and less costly than invasive ventilation.
The research findi...
Source: COVID-19 Diagnostics Jul 21, 2020 4 years ago
COVID-19 Diagnostics: According to newly published research from cardiologists at the University of Alberta, a new blood test that reliably predicts outcomes for heart failure patients could lead to new diagnostics and treatments for COVID-19 patients as well.
The medical researchers examined circulating angiotensin peptide levels in the blood of 110 people who were experiencing hear...
Source: COVID-19 Medications Jul 20, 2020 4 years ago
COVID-19 Medications: Synairgen, a British biotech company announced positive results from a clinical trial of its wholly-owned inhaled formulation of interferon beta in COVID-19 patients.
Synairgen indicated its nebulizer treatment resulted in a 79% lower risk of patients developing severe disease compared to those receiving a placebo. And the patients receiving the treatment &...
Source: Healthcare Innovations Jul 20, 2020 4 years ago
Healthcare Innovations: Researchers from Northeastern University-Boston have created a new sensor that is capable of detecting the SARS-CoV-2 coronavirus particle in the air. The new sensor would be a major game changer in the management of the current COVID-19 pandemic.
A gas sensor used to detect airborne SARS-CoV-2 virus in Professor Nian Sun’s lab in Egan
Research Center. Credit: Ruby ...
Source: Medical Innovations Jul 20, 2020 4 years ago
Medical Innovations: Researchers led by Massachusetts Institute of Technology along with colleagues from University of Seville-Spain, Benefits Science Technologies-Boston, Hartford HealthCare-Connecticit, Azienda Socio-Sanitaria Territoriale di Cremona-Italy and HM Hospitals Spain have created a new online COVID-19 Mortality Risk calculator for all healthcare professionals and even laymen to...
Source: COVID-19 Symptoms Jul 20, 2020 4 years ago
COVID-19 Symptoms: Researchers from King’s College London and Massachusetts General Hospital by detailed analysis of data from the COVID Symptom Study have identified six distinct ‘types’ of COVID-19, each distinguished by a particular cluster of symptoms.
The research team found that these types differed in the severity of the disease and the need for respiratory support duri...
Source: Hong Kong COVID-19 News Jul 20, 2020 4 years ago
Hong Kong COVID-19 News: SARS-CoV-2 infections are escalating and spreading out of control in Hong Kong with a record 108 new cases confirmed, the finance hub's leader said Sunday as she tightened social distancing measures to tackle the sudden surge in infections.
Hong Kong was one of the first places to be struck by the virus when it emerged from central China. However the city had ...
Source: COVID-19 Supplements Jul 20, 2020 4 years ago
COVID-19 Supplements: Vitamin D could play a supporting or adjuvant role in the treatment of COVID-19 disease as it is able to shut down certain pro-inflammatory responses to the SARS-CoV-2 coronavirus in a timely manner according to a new collaborative research involving 10 medical research entities and institutions including Imperial College London-UK, University of Oxford-UK, The U.S. National ...
COVID-19 News: Just when things could not become more complicated and worse, scientist have discovered a new hybrid strain of the fungus Aspergillus latus that is even more drug-resistant and worse it was found in certain COVID-19 patients causing serious lung infections and giving medical researchers new ‘headaches’ to deal with not one but two different dangerous pathogens.
...
Pharma News: One of the world’s biggest pharma giant Novartis, in a PR move publicly announced the launch an initiative to assist patients in low-income and lower-middle-income countries in getting access to affordable drugs for COVID-19.
The pharma company said that they are specifically making 15 drugs from its Sandoz division available that can be used to treat symptoms...
COVID-19 Drugs: Leading Biopharmaceuticals company Biocon has secured approval from the Drugs Controller General of India (DCGI) for its plaque psoriasis drug Itolizumab (ALZUMAb) for emergency use in Covid-19 patients.
The regulatory approval is for 25mg / 5ml injection solution of the medicine to treat cytokine release syndrome (CRS) in moderate to severe acute respiratory distress synd...
Source: COVID-19 Research Jul 20, 2020 4 years ago
COVID-19 Research: German researchers and virologists from the University Of Munich and Institute of Molecular Virology, ULM University have discovered that the spike protein Nsp1 from the SARS-Cov-2 has a central role in weakening the host anti-viral immune response by effectively shutting down production of proteins in the host.
It was found that the SARS-CoV Nsp1 induces a ...
COVID-19 Vaccine: It was announced that the First Phase-III clinical trial of Chinese state-owned pharmaceutical company Sinopharm's inactivated Covid-19 vaccine has started in Abu Dhabi.
Head of Abu Dhabi’s health department becomes first volunteer for
Covid-19 Phase III Chinese vaccine trials
Interestingly the UAE health authorities recently issued a permit for up to 15,000 vo...
Source: COVID-19 Supplements Jul 19, 2020 4 years ago
COVID-19 Supplements: A New study by researchers from Yale University show how lipidomic disruption and changes mark the severity of COVID-19 disease especially the start and progression of cytokine storms.
The research finding that is yet to be peer-reviewed is published on a preprint server. https://www.medrxiv.org/content/10.1101/2020.07.09.20149849v1
The research indirectly als...
Source: COVID-19 Supplements Jul 19, 2020 4 years ago
COVID-19 Supplements: Researchers from Spain, Peru and Colombia have collaborated to conduct a series of studies on the herb called Uncaria Tomentosa or Cat's claw on its efficacy against the SARS-CoV-2 coronavirus.
In an initial study using computational silico molecular docking analysis, it was found that the certain phytochemicals in the herb could inhibit the protease MPro re...
Source: COVID-19 Immunophenotyping Jul 19, 2020 4 years ago
COVID-19 Immunophenotyping: A major of the sign of SARS-CoV-2 infection is the broad-spectrum of disease severity. COVID-19 usually results in a mild disease course that resolves on its own. However, about 8 to 12% of patients develop severe symptoms that require intensive care with mechanical ventilation. Understanding this distinction, and uncovering the cause of the difference between mild dise...
COVID-19 Drugs: Iran is one of the worse hit countries by the COVID-19 crisis and initially as a result of drug shortages and misinformation, Iranian physicians were using hydroxychloroquine (HCQ) to treat many of its patients but as the lethal effects of the drug became known, many local researchers turned to drug-repurposing studies to find alternatives.
One such identified drug was Febuxostat....
Source: COVID-19 Supplements Jul 19, 2020 4 years ago
COVID-19 Supplements: Scientists from the Wuhan University of Bioengineering in China say that curcumin, a natural compound found in the spice turmeric, could help eliminate certain coronaviruses especially an alpha-group coronavirus that infects pigs.
The new research in China showed that curcumin can prevent transmissible gastroenteritis virus (TGEV), an alpha-group coronavirus that inf...
Source: COVID-19 Research Jul 19, 2020 4 years ago
COVID-19 Research: Researchers from Cleveland Clinic and Case Western Reserve University have identified genetic factors that may influence susceptibility to COVID-19.
These findings could pave the way for a personalized medicine approach for treating COVID-19 as it is emerging more day by day that COVID-19 is a highly complex disease with different pathogenesis paths in different i...
COVID-19 Updates: A study by German And Swedish researchers suggest that statins do not aggravate the risk of COVID-19 infection rather on the contrary may have some beneficial effect in some cases as they could reduce and even inhibit SARS-CoV-2 coronavirus entry into the cells of the human host.
The study findings were published on a preprint server and is yet to have been peer-reviewed. https:...
Source: COVID-19 Research Jul 18, 2020 4 years ago
COVID-19 Research: A new report by researchers from John Hopkins University School of Medicine suggests an infusion of cells that dampen the body's immune response might help individuals with severe cases of the new coronavirus recover more quickly.
In the report, two patients so sick with COVID-19 that they'd been put on a ventilator improved quickly when given an infusion of reg...
Source: India COVID-19 News Jul 18, 2020 4 years ago
India COVID-19 News: The COVID-19 situation in India is totally grim as epidemiological modeling experts and medical researchers from Bengaluru are claiming that reported figures are not the least accurate as India does not have a proper reporting structure in place coupled with the fact that state governments are trying to conceal the actual impact of the crisis and also hospitals and doctors do ...
Source: COVID-19 Diagnostics Jul 18, 2020 4 years ago
COVID-19 Diagnostics: Roughly between 8 to 12% of individuals with COVID-19 disease progresses to a severe or critical form, including the development of severe pneumonia that progresses to acute respiratory distress syndrome.
Although these forms sometimes occur early in the course of the disease, clinical observations generally describe a two-stage progression of the disease, beginning ...
COVID-19 Drugs: Dexamethasone’s much-awaited official results from a UK trial of the steroid dexamethasone were published finally a few hours ago in the New England Journal of Medicine, confirming its life-saving benefits for COVID-19 patients on ventilators but suggesting it may cause harm if given too early. https://www.nejm.org/doi/full/10.1056/NEJMoa2021436?query=featured_home
In...
COVID-19 Latest: Researchers from the University of California-Berkeley say that some individuals could be infected by two strain variations of the SARS-CoV-2 coronavirus at once, sending the immune system into overdrive. Such cases are also emerging globally with scientist warning that co-infections with two or more different strains could even render vaccines, antibodies and current drug protoco...
COVID-19 News: Scientists from the Montreal Neurological Institute, McGill University have discovered that the SARS-CoV-2 may be using a unique method of clathrin-mediated endocytosis to gain entry into the host cells.
The research findings are published on a preprint server and are pending peer review.
https://www.biorxiv.org/content/10.1101/2020.07.13.201509v2
The Canadian researc...
COVID-19 Vaccine: Moderna has announced that said its COVID-19 vaccine candidate mRNA-1273 will advance to a 30,000-participant Phase III trial later this month, following publication of additional positive Phase I data from a study led by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID).
The “COVE” Phase III study (NCT04470427) is expected to begin regis...
Source: COVID-19 Diagnostics Jul 17, 2020 4 years ago
COVID-19 Diagnostics: Researchers from Coney Island Hospital-New York in a new study have found that a simple rapid laboratory test, the eosinophil count, readily obtained from a routine complete blood cell count (CBC) can aid in the early recognition of COVID-19 in patients, as well as provide prognostic information.
Their research findings have been published in The Journal of the Ameri...
Source: COVID-19 Supplements Jul 17, 2020 4 years ago
COVID-19 Supplements: Medical researchers from University of California-Los Angeles, Beijing University and also Jinan University in Guangdong- China have discovered that a new stabilized nano-capsulized drug based on the antioxidant enzyme catalase could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
The research findings have been...
Medical Devices For COVID-19: Northwestern University Researchers together with Shirley Ryan AbilityLab have developed a new wearable medical device for continuous monitoring of COVID -19 patients after having conducted a study of existing consumer devices and other medical device wearables and found limitations in these devices.
Credit: Northwestern University
The new extremely sticker l...
COVID-19 Vaccine Updates: Data from the Phase 1 trial of COVID-19 vaccine by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13.6 million individuals across the globe
U.K. media yesterday began to report hints of data from the early-stage study of the vaccine candidate...
Source: COVID-19 Research Jul 17, 2020 4 years ago
COVID-19 Research: According to emerging research reports from New York, COVID-19 is associated with life-threatening blood clots in the arteries of the legs.
Researchers are saying that COVID-19 patients with symptoms of inadequate blood supply to the lower extremities tend to have larger clots and a significantly higher rate of amputation and death than uninfected individuals with the same con...
COVID-19 News: Cannabidiol or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.
Though more work, including clinical trials to determine optimal dosage and timing, is needed before CBD becomes part of the treatment for COVID-19, researchers at the Dental College of Georgia and Medical College of ...
Source: U.S. COVID-19 News Jul 16, 2020 4 years ago
U.S. COVID-19 News: The total number of official COVID-19 Infections in America is now 3.51 million and the total number of Americans who have died from the COVID-19 is 139,012 (almost coming to 140,000). It is reported that almost 1.64 million of those infected have ‘recovered’ while about 27,213 are in critical conditions throughout the country.
The US CDC had earlier said t...
COVID-19 Spread: Smart and cautious individuals are now avoiding the public toilets or restrooms and suddenly, portable camping potties and female funnels have become must-have products, selling out at camping stores and back-ordered online nationwide in America.
Melissa Paul, a merchandising manager at REI, where sales of the Luggable Loo and Go Anywhere portable toilets ...
Source: COVID-19 Immune Response Jul 16, 2020 4 years ago
COVID-19 Immune Response: Scientists from the Penn Institute of Immunology-University of Pennsylvania have discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.
Senior author Dr E. John Wherry, Ph.D., chair of the department of Systems Pharmacolog...
Source: COVID-19 Immunology Jul 16, 2020 4 years ago
COVID-19 Immunology: Medical researchers from a Singapore study have uncovered the presence of virus-specific T cell immunity in individuals who recovered from COVID-19 and SARS, as well as some healthy study subjects who had never been infected by either virus.
The new findings from the research by scientists from Duke-NUS Medical School, in close collaboration with the National Universi...
Biotech Startups: Utah based biotech startup; IDbyDNA’s explify platform for metagenomics analysis is transforming highly sophisticated research-only laboratory tools into practical diagnostics tools for easy routine hospital use.
With the new platform, doctors can now determine not just whether a patient has COVID-19, but also in the same test whether that patient has other respira...
Source: COVID-19 Transmission Jul 16, 2020 4 years ago
COVID-19 Transmission: Forget about the stupid idea proposed about immunity passports. If this new research is confirmed as really true, then maybe every human on the planet might have to start wearing tags to show blood groups types they belong to with blood groups who can be super spreaders being isolated from the rest!
In this new modeling study led by Dr Peter Ellis from the&nbs...
COVID-19 Drugs: A research team led by Hebrew University of Jerusalem (HU)'s Professor Dr Yaakov Nahmias says that a simple and inexpensive cholesterol-lowering drug called Fenofibrate (Tricor) that is been approved and on the market for decades could help downgrade the severity of COVID-19 disease.
The early research finding which looks promising has been published in the preprint section of...
COVID-19 Drugs: Heparin, a common drug, already approved by the US as an anticoagulant may also be a powerful tool in fighting COVID-19, according to research published in the journal: Antiviral Research. https://www.sciencedirect.com/science/article/abs/pii/S0166354220302874?via%3Dihub
The SARS-CoV-2, the virus that causes COVID-19, uses a surface spike protein to latch onto human c...
Source: COVID-19 Symptoms Jul 16, 2020 4 years ago
COVID-19 Symptoms: Although various skin rashes and breakouts are already being associated with COVID-19 now doctors in Spain doctors are reporting that rashes on the inside of the mouth are also occurring in some cases.
The study findings reporting this new emerging clinical symptom is published in the latest edition of the journal: JAMA Dermatology (Journal Of The American Medical Assoc...
Source: COVID-19 Antibodies Jul 15, 2020 4 years ago
COVID-19 Antibodies: A new study by researchers from Netherlands warns against the use of any COVID-19 therapies containing the IgG antibodies as these would react with the macrophages in the bodies of the infected and accelerate cytokine storms.
Though these IgG antibodies are more prevalent in large amounts in patients with severe COVID-19 conditions, they are also found in very small a...
COVID-19 Vaccine: The Phase 1 trial of an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes COVID-19 disease, was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to US NIH authorities.
The interim results of the trial were published yesterday in The New England Journal of Medicine....
Source: COVID-19 Heart Issues Jul 15, 2020 4 years ago
COVID-19 Heart Issues: To date more than 22% of all COVID-19-associated deaths are from cardiac complications, yet the mechanisms from which these complications arise have remained a topic of debate in the cardiology community.
One common hypothesis centers on the infection of the heart itself, but the understanding of which cells may be infected is unclear.
In order to address thi...
Source: COVID-19 Delirium Jul 15, 2020 4 years ago
COVID-19 Delirium: Trinity College Researchers in Dublin have identified a connection between aberrant energy metabolism in the brain and delirium ie the state of impaired cognition in individuals who are unwell. This mental symptom is proving common in individuals hospitalized with COVID-19.
The research findings were published in the peer-reviewed Journal of Neuroscience. https://w...
COVID-19 News: In a new detailed study conducted by researchers from the University Hospital of Salamanca in Spain that was funded by the Spanish Ministry For Science, in was found that more than 40 percent of 139 health care workers who had recovered from COVID-19 were found to have Pericarditis Or/And Myocarditis when they were examined about 10 weeks later. More than 42 % experienced symptoms a...
COVID-19 Rehab: As the number of confirmed global COVID-19 cases is fast approaching 14 million and many experts are saying that the numbers could actually be as high as 10 to 20 times that figure due to underreporting by many countries and also due to concealments in some cases, it is becoming apparent day by day and an emerging fact that there is a whole list of long term health complications ar...
COVID- 19 Vaccine: Canadian biophamaceutical company Medicago that is based in Quebec with branches in the U.S. announced that it has begun Phase I clinical trial for its plant-derived COVID-19 vaccine candidate. It has already administered the first doses of the candidate in healthy human subjects, and the company intends to initiate a Phase II/III trial this coming October.
Dr Nath...
COVID-19 Vaccine: American researchers from Duke University-Durham have made an important discovery about the spike protein SARS-CoV-2 that could have a broad impact on vaccine studies.
The S or spike protein is the structure that binds to host cell angiotensin-converting enzyme 2 (ACE2) to enable viral attachment and entry during the infection process. The spike protein is also...
Source: COVID-19 Research Jul 15, 2020 4 years ago
COVID-19 Research: According to an international study led by the University of Cincinnati College of Medicine, depressed mood or anxiety exhibited in COVID-19 patients may possibly be a sign that the SARS-CoV-2 coronavirus is affecting the central nervous system.
The research findings are published in the journal: Laryngoscope. https://onlinelibrary.wiley.com/doi/abs/10.1002/lary.28964
&...
Source: COVID-19 Research Jul 14, 2020 4 years ago
COVID-19 Research: Researchers from New York University Langone Health in a retrospective study, found that the viral load of SARS-CoV-2 collected from patients in the emergency department is significantly higher in patients with fewer or milder symptoms who did not require hospitalization, the opposite of what might be expected. They also found that a patient's history of cancer and cardiovas...
Source: COVID-19 Pandemic Jul 14, 2020 4 years ago
COVID-19 Pandemic: A modeling study by Imperial College London and Oxford University predicts that the global healthcare industry will be disrupted the next 5 years due to the COVID-19 pandemic and that there will be a huge surge in deaths for those who contract or are suffering from HIV, TB and Malaria.
Certain low- and middle-income countries (LMICs) could see HIV, tuber...
Source: COVID-19 Supplements-Zinc Jul 14, 2020 4 years ago
COVID-19 Supplements: It seems that certain doctors, (those unethical ones getting commissions from Pharma giants), fact checkers (those buffoons who failed in their careers and work as fact checkers for garbage companies like Facebook) and certain corrupted government authorities tend to have an affinity for always discounting the fact that vitamins, supplements and herbs could help in cert...